Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

npj Digital Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. npj digital medicine
  3. articles
  4. article
Personalised thrombo-embolic risk prediction after endometrial cancer surgery: an explainable AI approach using SHAP
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 27 May 2026

Personalised thrombo-embolic risk prediction after endometrial cancer surgery: an explainable AI approach using SHAP

  • Qing Zhou1,2 na1,
  • Fudan Liu1 na1,
  • Jiaxiu Li1,
  • Qiyin Zhou3,
  • Xiaorong Xiang4,
  • Cheng Dai5,
  • Lianli Hen6,
  • ShouLi Dao7,
  • Mingjie Zhang1,
  • Bowen Gao1,
  • Yuxi Li1,
  • Lin Xu8,
  • Yonghu Chang9 &
  • …
  • Donghong Wang1 

npj Digital Medicine (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cancer
  • Computational biology and bioinformatics
  • Diseases
  • Health care
  • Medical research
  • Risk factors

Abstract

To address the clinical challenge of postoperative lower extremity deep vein thrombosis (LEDVT) in endometrial cancer care, this study establishes an explainable machine learning framework for personalized risk prediction. Utilizing perioperative data from 841 patients across multiple centers, we evaluated 26 machine learning algorithms combined with diverse data augmentation techniques. The Support Vector Machine (SVM) model emerged as the most robust architecture, refined through recursive feature elimination to a concise four-variable set comprising postoperative D-dimer, age, fibrinogen, and clinical stage. The model demonstrated superior discriminative performance, achieving an area under the curve (AUC) of 0.828 in internal validation and 0.819 in an independent external cohort. To bridge the gap between “black-box" AI and clinical trust, we integrated SHapley Additive exPlanations (SHAP) to quantify individual feature contributions, revealing non-linear associations such as the critical risk threshold for D-dimer levels. Finally, a web-based decision support interface was implemented to provide real-time, interpretable risk assessments. By combining high predictive accuracy with transparent decision logic, this approach offers a precise tool for identifying high-risk patients and optimizing postoperative management in endometrial cancer care.

Acknowledgements

This work was supported in part by the Technology Plan Project (Qiankehe Foundation [2019] 1353), Guizhou Provincial 2022 College Students' Innovation and Entrepreneurship Training Program Project (202210661272), Graduate Research Fund Project of Zunyi Medical University (ZYK59), and Project of Guizhou Provincial Health Commission (D-605). We thank the participating hospitals for their support in data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Author notes
  1. These authors contributed equally: Qing Zhou, Fudan Liu.

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

    Qing Zhou, Fudan Liu, Jiaxiu Li, Mingjie Zhang, Bowen Gao, Yuxi Li & Donghong Wang

  2. School of Management, Zunyi Medical University, Zunyi, Guizhou, China

    Qing Zhou

  3. Department of Obstetrics and Gynecology, Yanhe Tujia Autonomous County People’s Hospital, Yanhe, Guizhou, China

    Qiyin Zhou

  4. Department of Respiratory and Critical Care Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China

    Xiaorong Xiang

  5. Department of Obstetrics and Gynecology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China

    Cheng Dai

  6. Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China

    Lianli Hen

  7. Department of Obstetrics and Gynecology, Liupanshui Maternal and Child Health Hospital, Liupanshui, Guizhou, China

    ShouLi Dao

  8. Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi, Guizhou, China

    Lin Xu

  9. School of Medical Information Engineering, Zunyi Medical University, Zunyi, Guizhou, China

    Yonghu Chang

Authors
  1. Qing Zhou
    View author publications

    Search author on:PubMed Google Scholar

  2. Fudan Liu
    View author publications

    Search author on:PubMed Google Scholar

  3. Jiaxiu Li
    View author publications

    Search author on:PubMed Google Scholar

  4. Qiyin Zhou
    View author publications

    Search author on:PubMed Google Scholar

  5. Xiaorong Xiang
    View author publications

    Search author on:PubMed Google Scholar

  6. Cheng Dai
    View author publications

    Search author on:PubMed Google Scholar

  7. Lianli Hen
    View author publications

    Search author on:PubMed Google Scholar

  8. ShouLi Dao
    View author publications

    Search author on:PubMed Google Scholar

  9. Mingjie Zhang
    View author publications

    Search author on:PubMed Google Scholar

  10. Bowen Gao
    View author publications

    Search author on:PubMed Google Scholar

  11. Yuxi Li
    View author publications

    Search author on:PubMed Google Scholar

  12. Lin Xu
    View author publications

    Search author on:PubMed Google Scholar

  13. Yonghu Chang
    View author publications

    Search author on:PubMed Google Scholar

  14. Donghong Wang
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Lin Xu, Yonghu Chang or Donghong Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Q., Liu, F., Li, J. et al. Personalised thrombo-embolic risk prediction after endometrial cancer surgery: an explainable AI approach using SHAP. npj Digit. Med. (2026). https://doi.org/10.1038/s41746-026-02782-4

Download citation

  • Received: 09 February 2026

  • Accepted: 12 May 2026

  • Published: 27 May 2026

  • DOI: https://doi.org/10.1038/s41746-026-02782-4

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Associated content

Collection

Evaluating the Real-World Clinical Performance of AI

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims and scope
  • Content types
  • Journal Information
  • About the Editors
  • Contact
  • Editorial policies
  • Calls for Papers
  • Journal Metrics
  • About the Partner
  • Open Access
  • Early Career Researcher Editorial Fellowship
  • Editorial Team Vacancies
  • News and Views Student Editor
  • Communication Fellowship

Publish with us

  • For Authors and Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

npj Digital Medicine (npj Digit. Med.)

ISSN 2398-6352 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer